Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Oncotelic Therapeutics, Inc. (MATN)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues   [+]0.01.70.00.00.00.00.00.0
            Revenue growth  -100.0%      -100.0%
Cost of goods sold  0.00.00.00.00.00.00.00.0
Gross profit  0.01.70.00.00.00.00.00.0
            Gross margin   100.0%      
Selling, general and administrative   [+]5.55.02.90.13.45.04.65.2
Research and development  3.74.31.40.610.58.89.17.4
EBITDA   [+]-9.1-7.2-4.3 -13.8-13.7-13.7-12.5
            EBITDA margin   -414.8%      
Depreciation  0.00.00.0 0.00.00.00.0
EBITA  -9.1-7.3-4.3-0.7-13.8-13.8-13.7-12.6
            EBITA margin   -416.9%      
Amortization of intangibles  0.10.30.10.0   0.1
EBIT   [+]-9.1-7.6-4.3-0.7-13.8-13.8-13.7-12.7
            EBIT margin   -435.7%      
Interest expense, net   [+]2.02.00.7 0.0-0.10.00.0
Other income (expense), net   [+]0.6-0.4-1.6 0.00.00.00.0
Pre-tax income  -10.5-10.0-6.6-0.7-13.8-13.7-13.7-12.6
Income taxes  -1.1-0.50.00.00.00.00.00.0
            Tax rate  10.7%4.7%0.0%0.0%0.0%0.0%0.0%0.0%
Minority interest  -1.1-0.5      
Net income  -9.4-9.5-6.6-0.7-13.8-13.7-13.7-12.6
            Net margin   -545.9%      
   
Basic EPS   [+]($0.03)($0.11)($0.11)($0.12)($0.52)($0.51)($0.54)($0.75)
Diluted EPS   [+]($0.03)($0.11)($0.11)($0.12)($0.52)($0.51)($0.54)($0.75)
   
Shares outstanding (basic)   [+]303.188.160.06.126.526.525.217.0
Shares outstanding (diluted)   [+]303.188.160.06.126.526.525.217.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy